Editorial comment on: Mechanisms of prostate atrophy after glandular botulinum neurotoxin type A injection: an experimental study in the rat.
نویسنده
چکیده
[5] Chuang YC, Chiang PH, Huang CC, Yoshimura N, Chancellor MB. Botulinumtoxin typeA improvesbenignprostatic hyperplasia symptoms in patients with small prostates. Urology 2005;66:775–9. [6] Doggweiler R, Zermann DH, Ishigooka M, Schmidt RA. Botoxinduced prostatic involution. Prostate 1998;37:44–50. [7] Lin ATL, Yang AH, Chen K-K. Effects of botulinum toxin A on the contractile function of dog prostate. Eur Urol 2007;52:582–9. [8] Dolly JO, Aoki KR. The structure and mode of action of different botulinum toxins. Eur J Neurol 2006;13(Suppl 4):1–9. [9] Chuang YC, Huang CC, Kang HY, et al. Novel action of botulinum toxin on the stromal and epithelial components of the prostate gland. J Urol 2006;175:158–63. [10] Chuang YC, Chancellor MB. The application of botulinum toxin in the prostate. J Urol 2006;176:2375–82. [11] Smith CP, Franks ME, McNeil BK, et al. Effect of botulinum toxin A on the autonomic nervous system of the rat lower urinary tract. J Urol 2003;169:1896–900. [12] Jones OM, Moore JA, Brading AF, Mortensen NJ. Botulinum toxin injection inhibitsmyogenic tone and sympathetic nerve function in the porcine internal anal sphincter. Colorectal Dis 2003;5:552–7. [13] Duggan MJ, Quinn CP, Chaddock JA, et al. Inhibition of release of neurotransmitters from rat dorsal root ganglia by a novel conjugate of a clostridium botulinum toxin A endopeptidase fragment and erythrina cristagalli lectin. Biol Chem 2002;277:34846–52. [14] Rapp DE, Turk KW, Bales GT, Cook SP. Botulinum toxin type A inhibits calcitonin gene-related peptide release from isolated rat bladder. J Urol 2006;175:1138–42. [15] Witte LPW, Chapple CR, de la Rosette JJMCH, Michel MC. Cholinergic innervation and muscarinic receptors in the human prostate. Eur Urol 2008;54:326–34. [16] Pennefather JN, Lau WA, Mitchelson F, Ventura S. The autonomic and sensory innervation of the smooth muscle of the prostate gland: a review of pharmacological and histological studies. Auton Pharmacol 2000;20:193–206. [17] Dinis P, Charrua A, Avelino A, et al. The distribution of sensory fibers immunoreactive for the TRPV1 (capsaicin) receptor in the human prostate. Eur Urol 2005;48:162–7. [18] Ramien M, Ruocco I, Cuello AC, St. Louis M, Ribeiro-da-Silva A. Parasympathetic nerve fibers invade the upper dermis following
منابع مشابه
Lysozyme gene treatment in testosterone induced benign prostate hyperplasia rat model and comparasion of its’ effectiveness with botulinum toxin injection
OBJECTIVES To compare the effects and histopathological changes of botulinum neurotoxin type A and lysozyme gene injections into prostate tissue within a testosterone induced benign prostate hyperplasia rat model. MATERIALS AND METHODS 40 male Wistar rats were randomized into four Groups. Group-1: Control, Group-2: Testosterone replacement, Group-3: Testosterone+botulinum neurotoxin type A, G...
متن کاملتهیه نانو واکسن نوترکیب نوروتوکسین بوتولینوم تیپ E بر پایه کیتوسان و مقایسه ایمنیزایی آن به دو روش تزریقی و خوراکی در موش سوری
Background and Objectives: Botulism syndrome is caused by one of the seven botulinum neurotoxins. The toxins binding domain have immunogenicity effect and can be used as a recombinant vaccine candidate against botulism disease. Due to the low immunogenicity of recombinant protein , the use of an appropriate vehicle for antigen delivery to target cells is inevitable. The purpose of this study ...
متن کاملEffect of Botulinum Neurotoxin A Injection into the Submucoperichondrium of the Nasal Septum in Reducing Idiopathic Non-Allergic Rhinitis and Persistent Allergic Rhinitis
Introduction: Submucoperichondrial injection of botulinum neurotoxin A (BTA) in the nasal septum is a promising therapeutic option in the treatment of persistent allergic rhinitis (AR) and non-allergic rhinitis, and is safer and more effective than intraturbinate injection in reducing clinical symptoms. Materials and Methods: Forty patients diagnosed with persistent AR or non-allergic rhiniti...
متن کاملThe effect of pH on recombinant C-terminal domain of Botulinum Neurotoxin type E (rBoNT/E-HCC)
Recombinant proteins are tending to be the most favorable vaccine-candidates against botulism. Recombinant Carboxy-terminal of botulinum neurotoxin serotype E (rBoNT/E-HCC) has been introduced as an efficient vaccine against botulism type E. In this report, we made an effort to investigate the effect of different pH on protein structure to assess if rBoNT/E-HCC could be used as a vaccine for or...
متن کاملIntraprostatic Botulinum Neurotoxin Type A Injection for Benign Prostatic Hyperplasia—A Spotlight in Reality
Botulinum toxin is a neurotoxin produced by the bacterium Clostridium botulinum. It inhibits the release of acetylcholine and other neurotransmitters from the nerve terminal. Botulinum toxin, specifically toxin type A (BoNT-A) has been used since the 1970s to reduce the muscular hypercontraction disorders. The application of BoNT-A in urology field started from intra-bladder injection for overa...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- European urology
دوره 56 1 شماره
صفحات -
تاریخ انتشار 2009